| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Exercise Physiology Program, University of Missouri-Columbia, Columbia, Missouri 65211
 |
ABSTRACT |
|---|
 TOP
 ABSTRACT
 INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Because n-3 fatty acid ingestion and aerobic exercise each has been associated with diminished postprandial lipemia (PPL), the purpose of this study was to evaluate the effect of a combination of these two factors on PPL. Sedentary men underwent a standard dietary preparation, including a 12-h fast before each trial. Six subjects performed a control trial (fat meal, 100 g fat) and an n-3 fatty acid trial (fat meal after 3 wk of n-3 fatty acid supplementation at 4 g/day). In a parallel experiment, six different subjects underwent a control trial and n-3 fatty acid supplementation + 60 min of exercise before ingestion of the fat meal. Supplementation with n-3 fatty acid significantly decreased baseline triglyceride (TG) concentrations but did not significantly affect PPL. The combination of n-3 fatty acid and exercise had no effect on the postprandial TG response. The present study suggests that n-3 fatty acid supplementation lowers resting TG concentrations but inhibits the beneficial effect of aerobic exercise on the postprandial TG response.
fish oil; high-density lipoprotein cholesterol; triglycerides
| |
INTRODUCTION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
THE CONSISTENT OBSERVATION of the positive relationship between postprandial lipemia (PPL) and cardiovascular disease (CVD) suggests that PPL may be a better predictor of CVD than fasting triglyceride (TG) levels (19). Ziogas et al. (33) showed that exercise training was associated with significantly lowered PPL. Zhang et al. (31) showed that a session of aerobic exercise (1 h of treadmill running) before ingestion of a high-fat meal significantly decreased PPL and elevated high-density-lipoprotein cholesterol (HDL-C) concentrations. Others also have observed a marked attenuating effect of aerobic exercise on PPL (2, 28).
Supplementation with n-3 fatty acid, ingested in the form of fish oils (FO), can also independently lower fasting TG levels and PPL (5, 12, 18, 24). The exercise and n-3 fatty acid treatment effects on PPL may be additive or synergistic, but no previous studies were uncovered that examined the combination of these two TG-lowering treatments on PPL. Therefore, the purpose of this study was to evaluate the effect of a combination of exercise and n-3 fatty acid ingestion on resting TG and PPL.
| |
METHODS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Subjects were 12 men, ages 19-38 yr. All had been sedentary for
the previous 6 mo. No subjects were taking dietary supplements beyond a
daily multivitamin. The subjects were randomly assigned to separate
experimental trials: FO or exercise + FO (ExFO). There were no
significant differences in the characteristics between the two groups
of subjects (Table 1), nor were there any statistical differences in dietary intake between the two groups (Table
2).
|
|
The subjects provided informed consent, as approved by the Institutional Review Board, and completed a physical activity questionnaire, a health questionnaire, and a 3-day diet record. Subjects with more than one major CVD risk factor or any disease symptom (1) were disqualified.
Before the trials, a maximal O2 consumption
(
O2 max) test was
performed on a treadmill, as previously described (30), to determine
the exercise intensity for the subsequent bout of aerobic exercise.
Body composition was assessed by hydrostatic weighing, with residual
volume measured by the helium dilution technique (27).
Preparatory diet and exercise. Subjects were instructed to maintain their normal diets and activity level during the course of the study. Before each trial, the subjects abstained from exercise for 48 h. On the day before trial 1, each subject completed a 1-day diet record and repeated the same diet before trial 2. Thus the subjects consumed the same kind of food and drink, quantity and quality, before both trials. The subjects also fasted for 12 h before each trial. Each subject was contacted 48 h before each trial to be reminded of the preparation protocol.
Treatments/trials.
In these two parallel experiments, subjects in the FO group performed a
control trial (fat meal only) and an experimental trial consisting of
FO supplementation, whereas the ExFO group performed the control trial
and an experimental trial consisting of exercise + FO supplementation
(Fig. 1).
|
O2 max. After the
exercise session, a blood sample was taken, the test meal was given,
and additional postmeal blood samples were collected.
Test meal. A standard fat-rich test meal was provided in each trial to magnify the postprandial TG and HDL-C response. The test meal (82.6% fat) was given in a milkshake form and was consumed within 10 min for each trial. The milkshake consisted of a combination of 270 ml of whipping cream and 65 g of specialty ice cream. This was a total of 980 kcal, 100 g of fat, 17 g of carbohydrate, and 3 g of protein.
n-3 Fatty acid FO supplement. The subjects were given n-3 fatty acid supplements (Super EPA-500, Bronson Pharmaceutical, St. Louis, MO) in the form of eight soft gel tablets per day for 3 wk. Each tablet contained 300 mg of eicosapentaenoic acid and 200 mg of docosahexaenoic acid, a total of 500 mg of n-3 fatty acids (4 g/day). The subjects ingested the capsules over the course of the day with their meals.
Standard meal and snack. A standard meal was ingested after the 8-h blood draw, and a standard snack was ingested at 11.5 h after the fat meal (12.5 h before the final blood draw), as previously described (31). Other than the provided meals and prescribed exercise, the subjects were instructed not to consume any other food or drink except water and not to exercise during the treatment periods.
Blood sample collection.
All blood samples were collected into EDTA-containing tubes from an
antecubital vein after the subject had been seated in an upright
position for 3 min. The blood was separated by centrifugation at
4°C for 15 min at 2,000 g (Beckman TJ-6 centrifuge), and
the plasma was transferred to a storage vial and stored at
70°C.
TG and HDL-C analyses. Plasma was analyzed for TG and HDL-C. All samples from a given subject were analyzed in a single run. Plasma TG and HDL-C were measured enzymatically using diagnostic kits (Sigma Diagnostics, St. Louis, MO) on a spectrophotometer (model DU-2, Beckman Instruments, Fullerton, CA), as previously described (30). The TG area scores under the TG-time curve, in which the change in TG levels from baseline to each postprandial time point was determined, and the area under the TG curve were determined by the trapezoidal rule. The mean intra-assay coefficient of variation for 10 runs of triplicate or quadruplicate samples was 2.5% for TG and 0.3% for HDL-C.
Fatty acid analysis. Fatty acids were analyzed in the TG and phospholipid fractions of plasma, according to the method of Sun (25), before and after the FO supplementation. This analysis provided a means of confirming the compliance of the subjects in taking the supplement. The mean coefficient of variation for 16 runs of triplicate samples was 3.2%.
Statistics. For within-group analyses, a two-way (trial × time) ANOVA with repeated measures was performed on TG and HDL-C concentrations, and a one-way ANOVA with repeated measures was performed on TG scores. Significant F ratios (P < 0.05) for time were followed with a Newman-Keuls post hoc test. For between-group comparisons (FO vs. ExFO), one-way ANOVAs were used to compare baseline and peak TG concentrations and TG area scores between the experimental trials.
| |
RESULTS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
The results from the maximal testing are given in Table 1. Analysis of individual 20:5 and 22:6 fatty acids indicated that all subjects used the supplement. Although no subject had more than trace amounts (<1%) of these fatty acids before the supplementation, all subjects in both experiments had measurable concentrations after supplementation, most of it residing in the phospholipid fraction. For all subjects, the range in the phospholipid fraction for 20:5 was 4.1-7.5% and the range for 22:6 was 2.6-4.9%.
The mean baseline (fasting) TG concentrations were 122.9 ± 66.7 and
136.8 ± 72.6 mg/dl in the FO and ExFO groups, respectively (P > 0.05; Table 3). Separately, the fasting
TG concentrations in each group before and after FO supplementation
were of borderline significance, whereas the combined means were
significantly different, with baseline TG 33% lower as a result of the
FO ingestion.
|
In the FO experiment, the FO trial was not significantly different from
the control trial (P = 0.08). For both trials, the TG
concentration was significantly different over time, with the concentration at 2, 4, and 6 h higher than the values at the
other time points (Fig. 2). The
mean TG area scores were not significantly different between the two
trials, whereas the peak TG concentrations approached statistical
significance (P = 0.07; Fig.
3).
|
|
In the ExFO trials, the average O2 consumption during the
submaximal exercise session was 2.08 ± 0.13 l/min, at a mean heart rate of 147 ± 14 beats/min and a respiratory exchange ratio of 0.94 ± 0.06. The average percent
O2 max was 63.0 ± 0.1, and the mean energy expenditure for the 60-min session was 619 ± 38 kcal.
In the ExFO treatment, the TG response in the ExFO trial was not
different from the control. However, the TG levels at 2 and 4 h were
higher than those at 0, 8, and 24 h (Fig.
4). The TG area score was not different
between the ExFO trial and control, nor was the ExFO peak TG
concentration significantly different from the control (Fig.
5).
|
|
In comparing the TG area scores of the two experimental trials, the FO trial score (299.6 ± 156.0) was not significantly different from the ExFO trial score (289.3 ± 265.6). In addition, the FO trial peak TG concentration (145.0 ± 42.9 mg/dl) was not significantly different from the ExFO trial TG peak (185.2 ± 83.8).
There were no statistical differences in the postprandial HDL-C
concentrations between trials for the FO and ExFO treatments (Table
4). A main effect for time did exist for
the ExFO treatment, in that the 8-h combined value was significantly
higher than the 4-h combined value.
|
| |
DISCUSSION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Fasting TG levels. The decrease in fasting TG levels after the FO supplementation is similar to many other reported observations (5, 10, 12). Harris and Muzio (12) reported a 32% decrease in plasma TG levels after 4 wk of supplementation compared with the 33% decrease for 3 wk in the present study on about the same n-3 fatty acid dose (~4 g/day). The mechanism for this TG-lowering effect of n-3 fatty acid appears to be the inhibition of TG synthesis and/or secretion in the liver (21).
Supplementation with n-3 fatty acid. The primary objective of this study was to determine whether the effect of FO + exercise on PPL was different from the effect of FO alone. We found that FO alone did not affect the total area under the postprandial TG curve but lowered fasting and tended to lower peak TG concentration. This finding agrees with the results of Marckmann, Bladbjerg, and Jespersen (17), who observed an 18% decline in peak PPL after 4 wk of n-3 fatty acid supplementation.
In contrast to the present findings, other investigators reported a decrease in the TG area score after n-3 fatty acid ingestion (5, 12). However, previous investigations have not controlled for fitness level of the subjects. Ziogas et al. (33), using men and women, demonstrated that aerobic training is associated with a lower postprandial TG response. This finding suggests that fitness status may be an important factor in determining postprandial TG levels and, therefore, should be considered in interpreting results from research on PPL. In the present study, all subjects were sedentary, and thus the results were not confounded by level of previous training.Combination of n-3 fatty acid and exercise. A session of aerobic exercise, when performed in conjunction with n-3 fatty acid supplementation, did not result in an attenuation of PPL. This was an unexpected result, because aerobic exercise (28, 31) and n-3 supplementation (5, 12) each have been shown to reduce PPL when expressed as TG area scores and peak TG concentrations. The exercise effect has been especially powerful with a 1-h session of aerobic exercise, reducing PPL up to 50% (31). In the present study, the postprandial TG concentration levels were similar after exercise + FO supplementation and the control trial. A logical conclusion from these data is that one treatment interferes with the action of the other. The inhibition of this lipid-lowering effect of FO by exercise has not been reported previously. In a study in which FO was coupled with exercise, Warner et al. (29) found that exercising 3 days/wk for 12 wk in conjunction with FO supplementation can lower fasting TG levels. However, the response was the same in those who exercised and took FO and those who only took FO. Although there did not appear to be a negative interaction between the two treatments in that study, nor was there an additive effect, as would be hypothesized.
Exercise may interfere with the PPL effects of n-3 fatty acid by the following mechanisms: 1) It may block the n-3 fatty acid inhibition of TG synthesis or secretion in the liver. Blood flow to the liver is reduced during exercise (4), which would suggest that exercise, like n-3 fatty acid, causes reduced TG release from liver to blood. A substantial portion of the PPL can originate from the liver (10). However, the exercise interference with the n-3 fatty acid effect occurred after exercise, a time when blood flow to the liver should be normalized. 2) Exercise may inhibit the n-3 fatty acid-induced clearance of TG from plasma. There are few data to support this concept, since exercise is known to stimulate lipoprotein lipase (LPL) activity in muscle (16, 22). In addition, most studies have indicated that n-3 fatty acid supplementation does not alter LPL activity (10, 18). These authors concluded that n-3 fatty acid does not affect clearance of TG via increased LPL activity. Thus an inhibition of LPL activity does not appear to be the mechanism of the exercise interference with n-3 fatty acid. On the other hand, n-3 fatty acids may interfere with the attenuating effect of aerobic exercise on PPL. At least two possibilities may be postulated: inhibition of the exercise-induced increase in LPL activity or inhibition of the exercise-induced increase in muscle blood flow. Authors who have reported an exercise-induced attenuation of PPL have attributed the effect to increased activity of LPL (2, 28, 31). Exercise has been shown to induce LPL gene expression in skeletal muscle (22, 23). LPL activity becomes elevated shortly after an exercise session, but the activity does not peak until 18 h after an exercise session and remains elevated for up to 30 h (14, 16). On the other hand, exercise appears to have no effect on the activity of LPL in adipose tissue (22). The presence of n-3 fatty acid may prevent the exercise effect on PPL by interfering with the function of LPL, perhaps by changing the composition of chylomicrons so that interaction with LPL is diminished or by increasing lipid oxidation (24). More likely, n-3 fatty acid may have a more direct effect on LPL activity. Muscle and adipose LPL activity have not been differentiated routinely after n-3 fatty acid ingestion. However, at least one study illustrated that n-3 fatty acid supplementation caused an effect similar to exercise, i.e., increased muscle LPL activity but no effect on adipose activity (13). Most investigators have reported no effects on heparin-releasable LPL activity with n-3 fatty acid supplementation (7, 10, 18). However, this finding is not unanimous, since Harris et al. (11) observed increases in endogenous (non-heparin) LPL activity. Thus the evidence suggests that a direct inhibition of muscle LPL by n-3 fatty acid seems unlikely. n-3 Fatty acid also may inhibit the LPL response via hormone actions. The most likely candidate for this effect is insulin. An exercise session has been shown to have a consistent inhibitory effect on insulin secretion (24), although n-3 fatty acid effects on insulin have been more equivocal (17, 28). However, at least one group of investigators reported an increase in insulin concentration after 2 mo of n-3 fatty acid supplementation (20), and insulin infusion has been shown to cause a decrease in muscle LPL activity and an increase in adipose LPL activity (9). Thus n-3 fatty acid may interfere with the exercise effect on muscle LPL activity via its effect on insulin release. A second possibility for the antagonistic effect of n-3 fatty acid is related to blood flow. Some authors have speculated that the increased TG clearance related to acute exercise is due to the elevated muscle blood flow during exercise, thus allowing more lipoprotein to come into association with LPL (23). It is possible that n-3 fatty acids inhibit blood flow to muscle during exercise. A decreased endurance exercise performance after n-3 fatty acid supplementation supports this possibility (3). There also is evidence that n-3 fatty acids actually enhance fingernail capillary blood flow (6), which may suggest that peripheral blood flow is enhanced after n-3 fatty acid supplementation and thus diverts blood flow from muscle. In addition, the LPL response to exercise appears to be delayed for several hours (14, 23), a finding that would argue against a blood flow mechanism. Thus the potential for interference of muscle blood flow by n-3 fatty acid requires further research. The entire hypothesis of an n-3 fatty acid inhibition on exercise effects appears to be a fruitful topic for future investigations. Another possible explanation for the nonsignificant results was that the number of subjects used did not allow sufficient statistical power. To evaluate this possibility, effect sizes were calculated using a method for calculating
2 (26). The 2
indicates the effect size as a function of total variance accounted for
by the independent variable. The key comparisons in this study relate
to the differences in the TG response between the experimental and
control trials in each experiment. In the FO experiment, the 2 for the trial comparison (P = 0.07) for TG
concentrations was 0.50, and a sample size of 11 would be needed to
achieve a statistically significant difference at a power of 0.80. In
the ExFO experiment, a similar calculation for trial (P = 0.18)
yielded an 2 of 0.33 and a required sample size of 21.
For the TG area scores in the FO (P = 0.60) and ExFO (P = 0.93) experiments, the 2 values were very low, and the
calculated required sample sizes would be 150 and infinity,
respectively. The TG area scores for the FO vs. the ExFO experimental
conditions also were not close to significantly different (P = 0.94), with an 2 of 0.0005, requiring a sample size of
infinity to achieve statistical significance with a power of 0.80. In
summary, the low number of subjects may have affected the results for
TG concentrations over time in the FO experiment. However, for most
comparisons and especially for those involving the ExFO experiment,
similar findings would be expected even with a very large sample size. Large sample sizes are not practical in experiments in which daily multiple blood sampling is required of the subjects. Although the
interference between n-3 fatty acid and exercise needs to be
confirmed, these unexpected results do not appear to be a result of
small sample size.
The HDL-C concentrations were not different between the control and
experimental trials of the FO and ExFO groups. In the ExFO experiment,
the 8-h HDL-C level was higher than the 4-h value. Likewise, Zhang et
al. (31) reported an elevation of HDL-C 8 h after the test meal in
subjects who exercised 12 h before the meal. Most studies have reported
that acute exercise increases HDL-C (2, 14, 31). However, none of these
studies used exercise in conjunction with n-3 supplementation,
which may influence the response of HDL metabolism to exercise.
On the other hand, other investigators have reported that n-3
fatty acid supplementation does not affect baseline HDL-C
concentrations (8, 18). This finding was confirmed in the present
study. In addition, our data suggest that n-3 fatty acid
supplementation for 3 wk does not affect the postprandial
HDL-C concentrations after a high-fat meal.
It is possible that changes in plasma volume induced by the aerobic
exercise may have affected the interpretation of the TG and HDL-C data.
Aerobic exercise has been shown to decrease plasma volume immediately
after exercise, and, in recovery, plasma volume has been shown to
expand; this expansion may persist to some degree for several hours
after exercise and thus potentially decrease concentration measurements
in blood (15). In a previous study (32), we observed only small changes
in plasma volume (<5%) caused by moderate-intensity exercise for 60 min. Regardless, the potential hemodilution several hours after an
exercise session would cause, at most, small decreases in the TG and
HDL-C concentrations in recovery, alterations that would not account
for the lack of an exercise-induced TG-lowering effect or the positive
exercise effect on HDL-C in recovery.
In conclusion, supplementation with n-3 fatty acid appears to
lower fasting and peak postprandial TG concentrations but may interfere
with the beneficial effect of acute exercise on PPL. In addition,
n-3 fatty acid supplementation does not appear to affect baseline
or postprandial HDL-C concentrations.
| |
ACKNOWLEDGEMENTS |
|---|
We thank John Zhang and William Harris for suggestions on earlier drafts of the manuscript.
| |
FOOTNOTES |
|---|
This work was supported in part by grants from Food for the 21st Century and the Elizabeth Hegarty Foundation.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: T. R. Thomas, Dept. of Nutritional Sciences, 104 Rothwell Gym, Univ. of Missouri-Columbia, Columbia, MO 65211 (E-mail: thomastr{at}missouri.edu).
Received 26 August 1999; accepted in final form 13 January 2000.
| |
REFERENCES |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
1.
ACSM's Guidelines for Testing and Prescription (14th ed.). Baltimore, MD: Williams & Wilkins, 1995.
2.
Aldred, HE,
Perry IC,
and
Hardman AE.
The effect of a single bout of brisk walking on postprandial lipemia in normolipidemic young adults.
Metabolism
43:
836-841,
1994[ISI][Medline].
3.
Ayre, KJ,
and
Hulbert AJ.
Dietary fatty acid profile affects endurance in rats.
Lipids
32:
1265-1270,
1997[ISI][Medline].
4.
Brooks, GA,
Fahey TD,
and
White TP.
Exercise Physiology. Mountain View, CA: Mayfield, 1996, p. 273-275.
5.
Brown, AJ,
and
Roberts DCK
Moderate fish oil intake improves lipemic response to a standard fat meal.
Arterioscler Thromb
11:
457-466,
1991
6.
Bruckner, G,
Webb P,
Greenwell L,
Chow C,
and
Richardson D.
Fish oil increases peripheral capillary blood cell velocity in humans.
Atherosclerosis
66:
237-245,
1987[ISI][Medline].
7.
Desager, JP,
Dricot J,
and
Harvengt C.
Hypotriglyceridemic action of 
-3 fatty acids in healthy subjects does not occur by enhanced lipoprotein lipase and hepatic lipase activities.
Res Commun Chem Pathol Pharmacol
65:
269-272,
1989[ISI][Medline].
8.
Eritsland, J,
Seljeflot I,
Abdelnoor M,
and
Arnesen H.
Long-term effects of n-3 fatty acids on serum lipids and glycaemic control.
Scand J Clin Lab Invest
54:
273-280,
1994[ISI][Medline].
9.
Farese, RV,
Yost TJ,
and
Eckel RH.
Tissue-specific regulation of lipoprotein lipase activity by insulin/glucose in normal-weight humans.
Metabolism
40:
214-216,
1991[ISI][Medline].
10.
Harris, WS,
Connor WE,
Alam N,
and
Illingworth R.
Reduction of postprandial triglyceridemia in humans by dietary n-3 fatty acids.
J Lipid Res
29:
1451-1460,
1988[Abstract].
11.
Harris, WS,
Grouping L,
Rombjor GS,
Walen AI,
Ontko JA,
Cheng Q,
and
Windsor SL.
Influence of n-3 fatty acid supplementation on the endogenous activities of plasma lipases.
Am J Clin Nutr
66:
254-260,
1997
12.
Harris, WS,
and
Muzio F.
Fish oil reduces postprandial triglyceride concentrations without accelerating lipid-emulsion removal rates.
Am J Clin Nutr
58:
68-74,
1993
13.
Herzberg, GR,
and
Rogerson M.
The effect of dietary fish oil on muscle and adipose tissue lipoprotein lipase.
Lipids
24:
351-353,
1989[ISI][Medline].
14.
Kantor, MA,
Cullinane EM,
Herbert PN,
and
Thompson PD.
Acute increase in lipoprotein lipase following prolonged exercise.
Metabolism
33:
454-457,
1984[ISI][Medline].
15.
Kargotich, S,
Goodman C,
Keast D,
and
Morton AR.
The influence of exercise-induced plasma volume changes on the interpretation of biochemical parameters used for monitoring exercise, training, and sport.
Sports Med
26:
101-117,
1998[ISI][Medline].
16.
Keins, B,
and
Richter EA.
Utilization of skeletal muscle triacylglycerol during postexercise recovery in humans.
Am J Physiol Endocrinol Metab
275:
E332-E337,
1998
17.
Marckmann, P,
Bladbjerg EM,
and
Jespersen J.
Dietary fish oil (4 g daily) and cardiovascular risk markers in healthy men.
Arterioscler Thromb Vasc Biol
17:
3384-3391,
1997
18.
Nozaki, S,
Garg A,
Vega GL,
and
Grundy SM.
Postheparin lipolytic activity and plasma lipoprotein response to -3 polyunsaturated fatty acids in patients with primary hypertriglyceridemia.
Am J Clin Nutr
53:
638-642,
1991
19.
Patsch, JR,
Miesenbock G,
Hopferwieser T,
Muhlberger V,
Knapp E,
Dunn JK,
and
Patsch AM, Jr.
Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state.
Arterioscler Thromb
12:
1336-1345,
1992
20.
Rivellese, A,
Maffettone A,
Iovine C,
DiMarino L,
Giovanni A,
Mancini M,
and
Riccardi G.
Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia.
Diabetes Care
19:
1207-1213,
1996[Abstract].
21.
Rustan, AC,
Nossen JO,
Christiansen EN,
and
Drevon CA.
Eicosapentaenoic acid reduces hepatic synthesis and secretion of triacylglycerol by decreasing the activity of acyl-coenzyme A:1,2-diacylglycerol acyltransferase.
J Lipid Res
29:
1417-1426,
1988[Abstract].
22.
Seip, RL,
Angelopoulos TJ,
and
Semenkovich CF.
Exercise induces human lipoprotein lipase gene expression in skeletal muscle but not adipose tissue.
Am J Physiol Endocrinol Metab
268:
E229-E236,
1995
23.
Seip, RL,
and
Semenkovich CF.
Skeletal muscle lipoprotein lipase: molecular regulation and physiological effects in relation to exercise.
In: Exercise and Sport Sciences Reviews, edited by Holloszy JO.. Baltimore, MD: Williams & Wilkins, 1998, p. 191-218.
24.
Sorensen, NS,
Marckmann P,
Hoy CE,
Van Duyvenvoorde W,
and
Princen HMG
Effect of fish-oil-enriched margarine on plasma lipids, low-density-lipoprotein particle composition, size, and susceptibility to oxidation.
Am J Clin Nutr
68:
235-241,
1998[Abstract].
25.
Sun, GY.
Preparation and analysis of acyl and alkenyl groups of glycerophospholipids from brain subcellular membranes.
In: Lipids and Related Compounds, edited by Boulton AA,
Baker GB,
and Horrocks LA.. Clifton, NJ: Humana, 1998, p. 63-82.
26.
Tabachnick, BG,
and
Fidell LS.
Using Mulitvariate Statistics. New York: Harper Collins College, 1996, p. 53-54.
27.
Thomas, TR,
and
Etheridge GL.
Hydrostatic weighing at residual volume and functional residual capacity.
J Appl Physiol
49:
157-159,
1980
28.
Tsetsonis, NV,
and
Hardman AE.
Effect of low and moderate intensity treadmill walking on postprandial lipemia in healthy young adults.
Eur J Appl Physiol
73:
419-426,
1996[ISI].
29.
Warner, JG, Jr,
Ullrich IH,
Albrink MJ,
and
Yeater RA.
Combined effects of aerobic exercise and -3 fatty acids in hyperlipidemic persons.
Med Sci Sports Exerc
21:
498-505,
1989[ISI][Medline].
30.
Williams, CM,
Moore F,
Morgan L,
and
Wright J.
Effects of n-3 fatty acids on postprandial triacylglycerol and hormone concentrations in normal subjects.
Br J Nutr
68:
655-666,
1992[ISI][Medline].
31.
Zhang, Q,
Thomas TR,
and
Ball SD.
Effect of exercise timing on postprandial lipemia and HDL cholesterol subfractions.
J Appl Physiol
85:
1516-1522,
1998
32.
Ziogas, G,
and
Thomas TR.
Dietary preparation before rest and exercise testing.
Nutrition
14:
11-16,
1998[ISI][Medline].
33.
Ziogas, G,
Thomas TR,
and
Harris WS.
Exercise training, postprandial hypertriglyceridemia, and LDL subfraction distribution.
Med Sci Sports Exerc
29:
986-991,
1997[ISI][Medline].
This article has been cited by other articles:
|
|
 |
|
  T. R. Thomas, K. E. Horner, M. M. Langdon, J. Q. Zhang, E. S. Krul, G. Y. Sun, and R. H. Cox Effect of exercise and medium-chain fatty acids on postprandial lipemia J Appl Physiol, April 1, 2001; 90(4): 1239 - 1246. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
